| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 01/13/2011 | CA2766861A1 In vivo tumor vasculature imaging |
| 01/12/2011 | EP2273255A1 Device and method for determining the concentration of a substance |
| 01/12/2011 | EP2272539A2 Truncated fragments of alpha-synuclein in lewy body disease |
| 01/12/2011 | EP2272538A1 Method of detecting bladder cancer |
| 01/12/2011 | EP2271371A2 Novel pei-peg graft copolymer coating of iron oxide nanoparticles for inflammation imaging |
| 01/12/2011 | EP1814598B1 Contrast agents to target extracellular matrix |
| 01/12/2011 | CN1909931B Ultrasound contrast agents for molecular imaging |
| 01/12/2011 | CN1675245B Monoclonal antibody hPAM4 |
| 01/12/2011 | CN101945672A Biodegradable contrast agents |
| 01/12/2011 | CN101942023A Human epidermic growth factor ferritin heavy chain subunit fusion protein, constructing method and use thereof |
| 01/12/2011 | CN101942022A Anti-human epidermal growth factor receptor single-chain antibody-ferritin heavy chain subunit protein and construction method and application thereof |
| 01/12/2011 | CN101940791A Dually-targeted pH-sensitive antineoplastic drug carrier material as well as preparation and application thereof |
| 01/12/2011 | CN101940781A New method for inhibiting synthesis of liver fat and preventing and treating fatty liver |
| 01/12/2011 | CN101940780A Zinc finger protein ZBTB20 in chondrocyte-specific knockout mouse model and application thereof |
| 01/12/2011 | CN101531800B Method for preparing poly(amidoamine)/carbon nanometer tube composite material for cancer cell targeting diagnosis |
| 01/11/2011 | US7867715 Determining effectivenss of immunoglobulin binding; immunoassay; vaccine efficacy; immunodiagnostics and allergies |
| 01/11/2011 | US7867511 Abuse potential reduction in abusable substance dosage form |
| 01/11/2011 | US7867476 detecting the polypeptide fragments of dystrophin protein cleavage by enteroviral protease 2A as a result of an enteroviral infection (Coxsackievirus infection) in the heart; presence of dystrophin cleavage products in the myocytes or blood of a subject is diagnostic for enteroviral infection |
| 01/11/2011 | US7867171 Management of gastro-intestinal disorders |
| 01/11/2011 | CA2429781C Linkable sialyl lewis x analogs |
| 01/06/2011 | WO2011002415A1 Synthesis and use of fluorophore-tagged antimalarials |
| 01/06/2011 | WO2011000208A1 Pharmaceutical composition containing dimethicone/ simethicone |
| 01/06/2011 | WO2010104819A3 Hollow gold nanospheres (haunss) and haunss-loaded microspheres useful in drug delivery |
| 01/06/2011 | WO2010098502A9 Imaging diagnostic agent and extracorporeal diagnostic agent for incurable neurological diseases |
| 01/06/2011 | WO2010094043A3 Gadolinium expressed lipid nanoparticles for magnetic resonance imaging |
| 01/06/2011 | WO2010028216A3 Porphyrazine optical and dual optical/mr contrast and therapeutic agents |
| 01/06/2011 | US20110004098 Ester imaging agents |
| 01/06/2011 | US20110003710 Selectin ligands useful in the diagnosis and treatment of cancer |
| 01/06/2011 | US20110002915 Random and non-random alkylene oxide polymer alloy compositions |
| 01/06/2011 | US20110002852 Stem cells for use in locating and targeting tumor cells |
| 01/06/2011 | US20110002851 Cationic Colloidal Carriers for Delivery of Active Agents to the Blood-Brain Barrier in the Course of Neuroinflammatory Diseases |
| 01/06/2011 | US20110002849 Therapy selection method |
| 01/06/2011 | US20110002848 Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies |
| 01/06/2011 | US20110002846 Cd24 as a brain tumor stem cell marker and a diagnostic and therapeutic target in primary neural and glial tumors of the brain |
| 01/06/2011 | US20110002844 Stabilization of macromolecular membranes |
| 01/06/2011 | US20110002843 Method of detecting myocardial dysfunction in patients having a history of asthma or bronchospasm |
| 01/05/2011 | EP2270170A1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 01/05/2011 | EP2270107A1 Compounds for Dual Photodiagnosis and Therapy |
| 01/05/2011 | EP2269659A1 Integrin targeted imaging agents |
| 01/05/2011 | EP2269654A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 01/05/2011 | EP2268321A1 Method of determining alanine transaminase (alt) activity by 13c-mr detection using hyperpolarised 13c-pyruvate |
| 01/05/2011 | EP2268320A1 Image-guided therapy of myocardial disease: composition, manufacturing and applications |
| 01/05/2011 | EP2268319A2 Precursors of lipid metabolism for the diagnosis and treatment of cancer |
| 01/05/2011 | EP2268318A2 A tumor model system useful to study multistage cancer |
| 01/05/2011 | EP2268317A2 Integrin targeting agents and in-vivo and in-vitro imaging methods using the same |
| 01/05/2011 | EP2268314A2 Use of pyrene to carry peptides across the blood brain barrier |
| 01/05/2011 | EP1603941B1 Inhibitors of extracellular hsp90 |
| 01/05/2011 | EP1294769B1 Antibodies that immunospecifically bind to blys |
| 01/05/2011 | DE102008064065B9 Farbstofflösung Dye solution |
| 01/05/2011 | CN101939384A Peptide imaging agents |
| 01/05/2011 | CN101474541B Integrated chip and device thereof, and method for preparing micrometre level dispersoid |
| 01/05/2011 | CN101439191B Synthesizing method of visible light induced zinc ion fluorescence angiographic reagent capable of being applied in cell/tissue/living body |
| 01/05/2011 | CN101389357B Tumor-selective fluorescent dye |
| 01/04/2011 | US7863499 Rodent animal model treated with doxorubicin, lipopolysaccharide (LPS), and p-chlorophenylalanine (PCPA) for use in identifying modulators of seizure disorders |
| 01/04/2011 | US7863222 shRNA library |
| 01/04/2011 | US7863047 Intracorporeal medicaments for photodynamic treatment of disease |
| 01/04/2011 | US7862800 sterilized adhesive with x-ray imagining capabilities; shelf-stable; iodo-substituted phenol (meth)acrylates as radiopaque agents; for bonding soft tissue or adheringly seal a vascular cavity |
| 01/04/2011 | US7862799 Sustained release of antibodies in milk; insertion of antigen releasing device in mammary glands lymph nodes |
| 01/04/2011 | US7862798 Vitamin-targeted imaging agents |
| 01/04/2011 | CA2129899C Dual carrier immunogenic construct |
| 01/04/2011 | CA2068654C Varicella-zoster virus antigen |
| 12/30/2010 | US20100331928 Visible light modulation of mitochondrial function in hypoxia and disease |
| 12/30/2010 | US20100330667 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 12/30/2010 | US20100330586 Method for identifying compounds for treatment of pain |
| 12/30/2010 | US20100329993 Method of fixing and expressing physiologically active substance |
| 12/30/2010 | US20100329992 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors |
| 12/30/2010 | US20100329991 Medicinal preparation particularly for the treatment of slipped discs hernias |
| 12/30/2010 | US20100329990 Luminescent markers |
| 12/30/2010 | US20100329989 In Vivo Labeling of Mammalian Cone Photoreceptors by Intravitreal Injection of Fluorescently Tagged Peanut Agglutinin |
| 12/30/2010 | US20100329988 Method for Identifying Within a Mammal a DNA Encoding A Physiologically Active Polypeptide |
| 12/30/2010 | US20100329987 Uses of Sperm Membrane Protein OBF |
| 12/30/2010 | US20100329986 Adult Hepatic Progenitor Cells and Methods of Use Thereof |
| 12/30/2010 | US20100329985 Treatment and prevention of inflammatory diseases and autoimmune diseases |
| 12/30/2010 | US20100329984 Respiratory dispersion for metered dose inhalers |
| 12/30/2010 | US20100329983 Compounds and methods for the detection of trpv-6 cancers and drug delivery |
| 12/30/2010 | US20100329982 Particles with inducible change of shape |
| 12/30/2010 | US20100329981 Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent |
| 12/30/2010 | US20100329980 Humanized anti-alpha 9 integrin antibodies and the uses thereof |
| 12/30/2010 | US20100329977 Method for imaging tumor tissue |
| 12/30/2010 | US20100329976 Nanoparticulate compositions of angiogenesis inhibitors |
| 12/29/2010 | WO2010151793A1 Therapeutic antibody target validation and screening in vivo |
| 12/29/2010 | WO2010151074A2 Photosensitizer containing conjugates of quantum dot-chlorine derivatives and composition for treating and diagnosing cancer containing same for photodynamic therapy |
| 12/29/2010 | WO2010148501A1 Soricidin derived peptides and methods for the detection of trpv-6 cancers and drug delivery |
| 12/29/2010 | WO2010062557A8 Multimodal imaging of atherosclerotic plaque targeted to lox-1 |
| 12/29/2010 | EP2267445A1 Methods of detecting small intestinal bacterial overgrowth (SIBO) in a human subject |
| 12/29/2010 | EP2265967A1 An agent for transporting nuclear spin order and for magnetic resonance imaging |
| 12/29/2010 | EP2265630A2 Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma |
| 12/29/2010 | EP2265292A2 Method for the synthesis of hollow spheres |
| 12/29/2010 | EP2265174A1 Functionalized magnetic nanoparticles and methods of use thereof |
| 12/29/2010 | EP1793868B1 Liposomal contrast agents for cest imaging |
| 12/29/2010 | EP1731500B1 5-aminolevulinic acid phosphate salt, process for producing the same and use thereof |
| 12/29/2010 | EP1635878B1 Peptide conjugate for magnetic resonance imaging of matrix metalloproteinases |
| 12/29/2010 | EP1540342B1 Methods and compositions for diagnosing hepatocellular carcinoma |
| 12/29/2010 | CN101932341A Mr imaging agent or medium compressing hzperpolarised 13c alanine and methods of imaging wherein such an imaging medium is used |
| 12/29/2010 | CN101932340A Method to produce hyperpolarised amino acids and aminosulphonic acids |
| 12/29/2010 | CN101928458A Preparation method of multifunctional nanometer composite particle constructed by modified polymine |
| 12/29/2010 | CN101928347A Anti-carcinoembryonic-antigen (CEA) antibody and application thereof |
| 12/29/2010 | CN101928327A Bifunctional tridentate pyrazolyl containing ligands for re and tc tricarbonyl complexes |
| 12/29/2010 | CN101928262A Biologically active methylene blue derivatives |
| 12/29/2010 | CN101927007A Method for imaging tumor tissue |